As the 2025 deadline for a 25% reduction in major NCDs draws near, Access Accelerated member organization, IFPMA unveils a new Global Health Progress report to mark the Global Week for Action on NCDs. Co-created alongside Access Accelerated and other partners, the report highlights the biopharmaceutical industry’s dedication to partnering cross-sectorally for enhanced global health and NCD outcomes.

Discover the efforts being made in the latest report. Download here.